相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
Age-dependent decline of neprilysin in Alzheimer's disease and normal brain:: Inverse correlation with Aβ levels
E. Hellstrom-Lindahl et al.
NEUROBIOLOGY OF AGING (2008)
Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology
R. O. Carare et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2008)
Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease
Roy O. Weller et al.
BRAIN PATHOLOGY (2008)
Absence of β-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia
Stephanie Bombois et al.
ARCHIVES OF NEUROLOGY (2007)
Antibody-mediated clearance of amyloid-β peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging
Claudia M. Prada et al.
JOURNAL OF NEUROSCIENCE (2007)
Aβ species removal after Aβ42 immunization
James A. R. Nicoll et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Amyloid-β peptide remnants in AN-1792-immunized Alzheimer's disease patients -: A biochemical analysis
R. Lyle Patton et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
A specific amyloid-β protein assembly in the brain impairs memory
S Lesné et al.
NATURE (2006)
Relationships in Alzheimer's disease between the extent of A beta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen
J Tian et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2006)
Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo
I Klyubin et al.
NATURE MEDICINE (2005)
Aβ-related angiitis:: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy
NJ Scolding et al.
BRAIN (2005)
Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD
AJ Bayer et al.
NEUROLOGY (2005)
Aβ vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease
E Masliah et al.
NEUROLOGY (2005)
A beta 42 immunization in Alzheimer's disease generates A beta N-terminal antibodies
M Lee et al.
ANNALS OF NEUROLOGY (2005)
Clinical manifestations of cerebral amyloid angiopathy-related inflammation
JA Eng et al.
ANNALS OF NEUROLOGY (2004)
Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition
DM Wilcock et al.
JOURNAL OF NEUROSCIENCE (2004)
Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease
I Ferrer et al.
BRAIN PATHOLOGY (2004)
Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease Pro-CAA position statement
JAR Nicoll et al.
NEUROBIOLOGY OF AGING (2004)
APOE and cerebral amyloid angiopathy in the elderly
S Love et al.
NEUROREPORT (2003)
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
JM Orgogozo et al.
NEUROLOGY (2003)
APOE ε4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of Aβ protein
K Chalmers et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2003)
Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease:: defining the perivascular route for the elimination of amyloid β from the human brain
SD Preston et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2003)
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide:: a case report
JAR Nicoll et al.
NATURE MEDICINE (2003)
Cerebral hemorrhage after passive anti-Aβ immunotherapy
M Pfeifer et al.
SCIENCE (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Two types of sporadic cerebral amyloid angiopathy
DR Thal et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Cerebral microvascular pathology in aging and Alzheimer's disease
E Farkas et al.
PROGRESS IN NEUROBIOLOGY (2001)
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice
T Wyss-Coray et al.
NATURE MEDICINE (2001)
Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy
BJ Backskai et al.
NATURE MEDICINE (2001)
Transforming growth factor-β1 induces α-smooth muscle actin expression and fibronectin synthesis in cultured human retinal pigment epithelial cells
SZ Stocks et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2001)
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
C Janus et al.
NATURE (2000)
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
D Morgan et al.
NATURE (2000)
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
M Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
Clearance of amyloid β-peptide from brain:: transport or metabolism?: Reply
N Iwata et al.
NATURE MEDICINE (2000)
Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4
JM Olichney et al.
ARCHIVES OF NEUROLOGY (2000)
Role of the low-density lipoprotein receptor-related protein in β-amyloid metabolism and Alzheimer disease
BT Hyman et al.
ARCHIVES OF NEUROLOGY (2000)
分享论文
